Follow-up after radiological intervention in oncology: ECIO-ESOI evidence and consensus-based recommendations for clinical practice.

Details

Ressource 1Download: 32676924_BIB_7814FBC601D6.pdf (574.50 [Ko])
State: Public
Version: Final published version
License: CC BY 4.0
Serval ID
serval:BIB_7814FBC601D6
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Follow-up after radiological intervention in oncology: ECIO-ESOI evidence and consensus-based recommendations for clinical practice.
Journal
Insights into imaging
Author(s)
Maas M., Beets-Tan R., Gaubert J.Y., Gomez Munoz F., Habert P., Klompenhouwer L.G., Vilares Morgado P., Schaefer N., Cornelis F.H., Solomon S.B., van der Reijd D., Bilbao J.I.
ISSN
1869-4101 (Print)
ISSN-L
1869-4101
Publication state
Published
Issued date
16/07/2020
Peer-reviewed
Oui
Volume
11
Number
1
Pages
83
Language
english
Notes
Publication types: Journal Article
Publication Status: epublish
Abstract
Interventional radiology plays an important and increasing role in cancer treatment. Follow-up is important to be able to assess treatment success and detect locoregional and distant recurrence and recommendations for follow-up are needed. At ECIO 2018, a joint ECIO-ESOI session was organized to establish follow-up recommendations for oncologic intervention in liver, renal, and lung cancer. Treatments included thermal ablation, TACE, and TARE. In total five topics were evaluated: ablation in colorectal liver metastases (CRLM), TARE in CRLM, TACE and TARE in HCC, ablation in renal cancer, and ablation in lung cancer. Evaluated modalities were FDG-PET-CT, CT, MRI, and (contrast-enhanced) ultrasound. Prior to the session, five experts were selected and performed a systematic review and presented statements, which were voted on in a telephone conference prior to the meeting by all panelists. These statements were presented and discussed at the ECIO-ESOI session at ECIO 2018. This paper presents the recommendations that followed from these initiatives. Based on expert opinions and the available evidence, follow-up schedules were proposed for liver cancer, renal cancer, and lung cancer. FDG-PET-CT, CT, and MRI are the recommended modalities, but one should beware of false-positive signs of residual tumor or recurrence due to inflammation early after the intervention. There is a need for prospective preferably multicenter studies to validate new techniques and new response criteria. This paper presents recommendations that can be used in clinical practice to perform the follow-up of patients with liver, lung, and renal cancer who were treated with interventional locoregional therapies.
Keywords
Interventional radiology, Liver, Lung cancer, Oncology, Recommendations
Pubmed
Open Access
Yes
Create date
20/07/2020 9:05
Last modification date
15/01/2021 7:10
Usage data